Free Trial

NICE (NICE) Financials

NICE logo
$162.88 +2.94 (+1.84%)
Closing price 04:00 PM Eastern
Extended Trading
$160.56 -2.32 (-1.42%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for NICE

Annual Income Statements for NICE

This table shows NICE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
443 338 266 199 196 186 159 143 117 259 103
Consolidated Net Income / (Loss)
443 338 266 199 196 186 159 143 117 259 103
Net Income / (Loss) Continuing Operations
443 338 266 199 196 186 159 143 123 141 100
Total Pre-Tax Income
605 458 345 241 237 234 187 130 144 171 110
Total Operating Income
546 435 335 264 242 239 198 150 134 166 106
Total Gross Profit
1,826 1,609 1,498 1,297 1,086 1,042 948 863 678 623 568
Total Revenue
2,735 2,378 2,181 1,921 1,648 1,574 1,445 1,332 1,016 927 872
Operating Revenue
2,735 2,378 2,181 1,921 1,648 1,574 1,445 1,332 1,016 927 872
Total Cost of Revenue
910 768 684 624 562 532 497 469 338 304 304
Operating Cost of Revenue
910 768 684 624 562 532 497 469 338 304 304
Total Operating Expenses
1,280 1,174 1,162 1,033 844 803 750 713 544 457 462
Selling, General & Admin Expense
277 252 247 225 181 168 153 129 117 90 83
Marketing Expense
642 599 610 536 445 442 413 361 268 226 231
Research & Development Expense
361 323 306 271 218 194 184 181 142 128 123
Total Other Income / (Expense), net
59 22 10 -23 -4.86 -4.44 -11 -20 10 5.30 3.77
Other Income / (Expense), net
59 22 10 -23 -4.86 -4.44 -11 -20 10 5.30 3.77
Income Tax Expense
162 119 79 41 41 48 27 -14 21 31 9.91
Basic Earnings per Share
$6.97 $5.32 $4.17 $3.15 $3.13 $2.99 $2.60 $2.37 $1.96 $4.35 $1.74
Weighted Average Basic Shares Outstanding
63.48M 63.59M 63.79M 63.19M 62.71M 62.12M 61.39M 60.44M 59.67M 59.55M 59.36M
Diluted Earnings per Share
$6.76 $5.11 $4.00 $2.98 $2.98 $2.88 $2.52 $2.31 $1.92 $4.22 $1.69
Weighted Average Diluted Shares Outstanding
65.51M 66.27M 66.47M 66.90M 65.96M 64.66M 63.31M 62.12M 61.04M 61.28M 60.90M
Weighted Average Basic & Diluted Shares Outstanding
63.25M 62.87M 63.63M 63.48M 63.05M 62.40M 61.77M 60.93M 59.99M 59.53M 59.25M

Quarterly Income Statements for NICE

No quarterly income statements for NICE are available.


Annual Cash Flow Statements for NICE

This table details how cash moves in and out of NICE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
-28 -20 154 -64 214 -14 -86 171 -169 138 68
Net Cash From Operating Activities
833 561 480 462 480 374 397 395 228 252 182
Net Cash From Continuing Operating Activities
833 561 480 462 480 374 397 395 228 252 182
Net Income / (Loss) Continuing Operations
443 338 266 199 196 186 159 143 117 259 103
Consolidated Net Income / (Loss)
443 338 266 199 196 186 159 143 117 259 103
Depreciation Expense
205 167 177 184 182 173 157 156 78 58 73
Amortization Expense
-8.03 7.10 13 26 13 9.18 8.07 14 2.82 2.80 2.07
Non-Cash Adjustments To Reconcile Net Income
198 202 205 183 121 98 68 56 46 -118 25
Changes in Operating Assets and Liabilities, net
-5.01 -154 -181 -131 -32 -92 3.81 25 -16 51 -21
Net Cash From Investing Activities
-397 -294 -152 -261 -465 -344 -461 -213 -800 -28 -8.93
Net Cash From Continuing Investing Activities
-397 -294 -152 -261 -465 -344 -461 -213 -800 -28 -8.93
Purchase of Property, Plant & Equipment
-100 -84 -82 -67 -63 -62 -64 -68 -36 -18 -18
Acquisitions
-65 -415 -30 -143 -147 -26 -105 -76 -1,156 0.00 0.00
Purchase of Investments
-938 -230 -396 -322 -583 -619 -430 -133 -49 -289 -144
Sale and/or Maturity of Investments
705 436 356 271 329 363 137 64 450 93 153
Net Cash From Financing Activities
-457 -290 -164 -262 197 -43 -16 -15 405 -79 -102
Net Cash From Continuing Financing Activities
-457 -290 -164 -262 197 -43 -16 -15 405 -79 -102
Repayment of Debt
-192 -2.63 -20 -177 -215 0.00 -0.88 -260 -1.09 0.00 0.00
Repurchase of Common Equity
-369 -288 -145 -73 -48 -47 -26 -24 -44 -68 -94
Payment of Dividends
-3.04 -1.77 -0.38 -16 0.00 0.00 - -9.64 -38 -38 -38
Issuance of Common Equity
3.06 2.57 0.95 4.43 8.87 5.43 19 19 24 28 30
Other Financing Activities, net
105 0.00 0.00 - -0.18 -0.82 -8.44 0.00 0.00 -0.30 1.05
Effect of Exchange Rate Changes
-6.91 2.64 -8.43 -2.11 1.87 -0.98 -5.78 4.42 -2.55 -6.11 -3.56
Cash Interest Paid
0.24 1.22 2.97 0.69 7.83 11 12 7.91 2.20 0.11 0.12
Cash Income Taxes Paid
120 210 124 97 83 65 43 33 28 54 33

Quarterly Cash Flow Statements for NICE

No quarterly cash flow statements for NICE are available.


Annual Balance Sheets for NICE

This table presents NICE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
5,296 5,118 4,854 4,710 4,233 3,610 3,207 2,845 2,632 1,850 1,633
Total Current Assets
2,505 2,313 2,417 2,298 1,942 876 861 693 509 655 485
Cash & Equivalents
482 512 530 379 442 228 242 328 157 326 187
Short-Term Investments
1,140 896 1,042 1,046 1,022 211 244 64 30 99 66
Accounts Receivable
644 585 519 396 303 320 288 231 260 177 156
Prepaid Expenses
239 198 205 185 175 117 87 70 62 44 40
Other Current Assets
0.00 122 122 293 - - - - - - -
Plant, Property, & Equipment, net
185 174 159 146 138 142 140 118 88 41 40
Total Noncurrent Assets
2,606 2,630 2,278 2,267 2,153 2,593 2,206 2,034 2,035 1,154 1,107
Goodwill
1,850 1,822 1,617 1,607 1,503 1,378 1,366 1,318 1,285 651 660
Intangible Assets
231 306 210 295 366 411 508 551 619 68 110
Noncurrent Deferred & Refundable Income Taxes
219 179 117 55 33 31 12 12 14 14 19
Other Noncurrent Operating Assets
306 324 334 310 251 230 74 19 19 17 19
Total Liabilities & Shareholders' Equity
5,296 5,118 4,854 4,710 4,233 3,610 3,207 2,845 2,632 1,850 1,633
Total Liabilities
1,693 1,763 1,799 1,872 1,644 1,353 1,191 1,096 1,121 434 419
Total Current Liabilities
1,474 1,120 1,141 1,270 1,044 941 625 523 473 379 378
Short-Term Debt
459 209 209 396 260 252 0.00 0.00 21 0.00 -
Accounts Payable
704 595 579 524 450 422 404 339 302 235 202
Current Deferred Revenue
299 303 339 330 312 246 221 185 150 131 123
Other Current Liabilities
13 14 14 20 22 22 0.00 - - - -
Total Noncurrent Liabilities
218 643 658 603 600 412 566 572 648 56 41
Long-Term Debt
0.00 457 455 429 421 213 456 448 444 0.00 -
Noncurrent Deferred Revenue
66 52 57 67 36 26 35 38 23 20 -
Noncurrent Deferred & Payable Income Tax Liabilities
1.97 8.60 7.34 7.43 32 53 44 58 147 15 14
Other Noncurrent Operating Liabilities
150 125 138 100 110 120 31 29 34 18 19
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,603 3,355 3,055 2,838 2,588 2,257 2,017 1,750 1,511 1,415 1,213
Total Preferred & Common Equity
3,590 3,341 3,042 2,825 2,564 2,257 2,017 1,750 1,511 1,415 1,213
Total Common Equity
3,590 3,341 3,042 2,825 2,564 2,257 2,017 1,750 1,511 1,415 1,213
Common Stock
2,298 2,142 1,970 1,837 1,701 1,587 1,519 1,439 1,336 1,252 1,189
Retained Earnings
2,702 2,263 1,926 1,654 1,454 1,258 1,072 851 711 632 412
Treasury Stock
-1,339 -1,005 -743 -626 -574 -554 -527 -508 -489 -445 -377
Accumulated Other Comprehensive Income / (Loss)
-71 -59 -111 -40 -17 -33 -47 -33 -47 -24 -11
Noncontrolling Interest
13 13 13 13 25 0.00 - - - - -

Quarterly Balance Sheets for NICE

No quarterly balance sheets for NICE are available.


Annual Metrics And Ratios for NICE

This table displays calculated financial ratios and metrics derived from NICE's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
15.05% 9.00% 13.54% 16.57% 4.71% 8.96% 8.44% 31.18% 9.57% 6.29% 6.14%
EBITDA Growth
26.84% 18.21% 18.56% 4.44% 3.65% 18.40% 17.25% 33.34% -3.05% 25.17% 6.00%
EBIT Growth
32.14% 32.54% 43.52% 1.45% 1.24% 25.47% 44.00% -10.26% -15.71% 55.74% 38.64%
NOPAT Growth
24.19% 24.63% 18.13% 9.05% 5.77% 12.33% 1.68% 45.11% -16.10% 40.84% 93.93%
Net Income Growth
30.83% 27.21% 33.49% 1.47% 5.62% 16.67% 11.20% 22.55% -54.83% 151.11% 86.48%
EPS Growth
32.29% 27.75% 34.23% 0.00% 3.47% 14.29% 9.09% 20.31% -54.50% 149.70% 89.89%
Operating Cash Flow Growth
48.31% 17.03% 3.88% -3.85% 28.37% -5.66% 0.49% 72.94% -9.56% 38.44% 46.67%
Free Cash Flow Firm Growth
500.94% -141.01% 262.54% -258.32% -29.03% 92.45% -46.25% 118.73% -528.14% 33.45% 397.23%
Invested Capital Growth
-6.61% 21.62% -4.01% 23.96% 3.74% -0.06% 4.16% -1.09% 185.17% -13.62% -9.90%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
66.75% 67.69% 68.66% 67.50% 65.90% 66.21% 65.61% 64.82% 66.74% 67.25% 65.19%
EBITDA Margin
29.31% 26.59% 24.52% 23.48% 26.21% 26.47% 24.36% 22.53% 22.17% 25.05% 21.27%
Operating Margin
19.96% 18.31% 15.37% 13.74% 14.69% 15.17% 13.68% 11.27% 13.21% 17.92% 12.19%
EBIT Margin
22.11% 19.25% 15.83% 12.52% 14.39% 14.88% 12.93% 9.73% 14.23% 18.49% 12.62%
Profit (Net Income) Margin
16.18% 14.23% 12.19% 10.37% 11.91% 11.81% 11.03% 10.76% 11.51% 27.93% 11.82%
Tax Burden Percent
73.18% 73.91% 77.01% 82.80% 82.78% 79.35% 85.34% 110.51% 80.92% 151.00% 93.65%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
26.82% 26.09% 22.99% 17.20% 17.22% 20.65% 14.66% -10.51% 14.82% 17.99% 9.00%
Return on Invested Capital (ROIC)
15.81% 13.51% 11.77% 10.81% 11.30% 10.88% 9.88% 9.86% 10.01% 21.30% 13.36%
ROIC Less NNEP Spread (ROIC-NNEP)
11.29% 11.50% 10.73% 13.60% 11.92% 11.77% 15.16% -34.49% 9.19% 3.13% 12.05%
Return on Net Nonoperating Assets (RNNOA)
-3.09% -2.96% -2.74% -3.46% -3.20% -2.18% -1.42% -1.08% -2.02% -1.61% -4.84%
Return on Equity (ROE)
12.72% 10.56% 9.03% 7.34% 8.10% 8.70% 8.46% 8.79% 7.99% 19.69% 8.52%
Cash Return on Invested Capital (CROIC)
22.65% -5.99% 15.86% -10.59% 7.63% 10.94% 5.80% 10.96% -86.14% 35.92% 23.78%
Operating Return on Assets (OROA)
11.62% 9.18% 7.22% 5.38% 6.05% 6.87% 6.17% 4.73% 6.45% 9.84% 6.69%
Return on Assets (ROA)
8.50% 6.79% 5.56% 4.46% 5.01% 5.45% 5.27% 5.23% 5.22% 14.86% 6.27%
Return on Common Equity (ROCE)
12.67% 10.51% 8.99% 7.29% 8.06% 8.70% 8.46% 8.79% 7.99% 19.69% 8.52%
Return on Equity Simple (ROE_SIMPLE)
12.33% 10.13% 8.74% 7.05% 7.66% 8.24% 7.90% 8.19% 7.74% 18.29% 8.49%
Net Operating Profit after Tax (NOPAT)
400 322 258 219 200 189 169 166 114 136 97
NOPAT Margin
14.61% 13.53% 11.83% 11.37% 12.16% 12.04% 11.67% 12.45% 11.25% 14.70% 11.09%
Net Nonoperating Expense Percent (NNEP)
4.52% 2.02% 1.04% -2.79% -0.62% -0.89% -5.28% 44.36% 0.82% 18.17% 1.31%
Return On Investment Capital (ROIC_SIMPLE)
9.84% 8.00% 6.94% - - - - - - - -
Cost of Revenue to Revenue
33.25% 32.31% 31.34% 32.50% 34.10% 33.79% 34.39% 35.18% 33.26% 32.75% 34.81%
SG&A Expenses to Revenue
10.12% 10.61% 11.30% 11.73% 10.97% 10.68% 10.61% 9.69% 11.48% 9.75% 9.56%
R&D to Revenue
13.18% 13.57% 14.03% 14.12% 13.24% 12.31% 12.73% 13.60% 13.94% 13.86% 14.12%
Operating Expenses to Revenue
46.79% 49.38% 53.29% 53.76% 51.21% 51.05% 51.93% 53.55% 53.53% 49.33% 53.00%
Earnings before Interest and Taxes (EBIT)
605 458 345 241 237 234 187 130 144 171 110
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
802 632 535 451 432 417 352 300 225 232 185
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.97 3.80 4.01 6.78 6.90 4.25 3.27 3.15 2.70 2.37 2.45
Price to Tangible Book Value (P/TBV)
7.08 10.46 10.04 20.74 25.47 20.49 46.37 0.00 0.00 4.82 6.70
Price to Revenue (P/Rev)
3.90 5.34 5.60 9.96 10.74 6.09 4.56 4.14 4.02 3.62 3.41
Price to Earnings (P/E)
24.13 37.53 45.90 96.08 90.11 51.55 41.38 38.48 34.93 12.96 28.87
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.70% 0.93% 1.13% 1.29%
Earnings Yield
4.14% 2.66% 2.18% 1.04% 1.11% 1.94% 2.42% 2.60% 2.86% 7.71% 3.46%
Enterprise Value to Invested Capital (EV/IC)
3.90 4.58 5.27 8.29 9.38 5.21 3.63 3.25 2.52 4.26 3.61
Enterprise Value to Revenue (EV/Rev)
3.48 5.03 5.19 9.66 10.28 5.76 4.37 4.08 4.20 2.73 2.84
Enterprise Value to EBITDA (EV/EBITDA)
11.88 18.93 21.15 41.14 39.21 21.76 17.95 18.11 18.94 10.88 13.35
Enterprise Value to EBIT (EV/EBIT)
15.75 26.15 32.76 77.12 71.40 38.70 33.84 41.92 29.50 14.74 22.50
Enterprise Value to NOPAT (EV/NOPAT)
23.85 37.20 43.83 84.92 84.52 47.86 37.46 32.78 37.30 18.55 25.60
Enterprise Value to Operating Cash Flow (EV/OCF)
11.44 21.32 23.58 40.18 35.26 24.23 15.93 13.77 18.68 10.01 13.59
Enterprise Value to Free Cash Flow (EV/FCFF)
16.65 0.00 32.51 0.00 125.23 47.59 63.82 29.51 0.00 11.00 14.39
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.13 0.20 0.22 0.29 0.26 0.21 0.23 0.26 0.31 0.00 0.00
Long-Term Debt to Equity
0.00 0.14 0.15 0.15 0.16 0.09 0.23 0.26 0.29 0.00 0.00
Financial Leverage
-0.27 -0.26 -0.26 -0.25 -0.27 -0.19 -0.09 0.03 -0.22 -0.51 -0.40
Leverage Ratio
1.50 1.56 1.62 1.65 1.62 1.60 1.61 1.68 1.53 1.32 1.36
Compound Leverage Factor
1.50 1.56 1.62 1.65 1.62 1.60 1.61 1.68 1.53 1.32 1.36
Debt to Total Capital
11.29% 16.57% 17.87% 22.53% 20.83% 17.08% 18.44% 20.37% 23.54% 0.00% 0.00%
Short-Term Debt to Total Capital
11.29% 5.20% 5.63% 10.81% 7.95% 9.24% 0.00% 0.00% 1.07% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 11.37% 12.24% 11.72% 12.89% 7.84% 18.44% 20.37% 22.46% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.33% 0.33% 0.36% 0.35% 0.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
88.37% 83.10% 81.77% 77.12% 78.41% 82.92% 81.56% 79.63% 76.46% 100.00% 100.00%
Debt to EBITDA
0.57 1.05 1.24 1.83 1.58 1.12 1.30 1.49 2.07 0.00 0.00
Net Debt to EBITDA
-1.45 -1.17 -1.70 -1.33 -1.81 -1.24 -0.78 -0.26 0.80 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.72 0.85 0.95 0.98 0.51 1.30 1.49 1.97 0.00 0.00
Debt to NOPAT
1.15 2.07 2.58 3.78 3.40 2.45 2.70 2.70 4.07 0.00 0.00
Net Debt to NOPAT
-2.91 -2.31 -3.51 -2.74 -3.91 -2.73 -1.63 -0.47 1.57 0.00 0.00
Long-Term Debt to NOPAT
0.00 1.42 1.76 1.96 2.10 1.13 2.70 2.70 3.89 0.00 0.00
Altman Z-Score
5.63 5.98 5.63 7.46 7.77 5.37 4.52 4.13 3.15 6.10 5.44
Noncontrolling Interest Sharing Ratio
0.39% 0.42% 0.44% 0.69% 0.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.70 2.06 2.12 1.81 1.86 0.93 1.38 1.32 1.08 1.73 1.28
Quick Ratio
1.54 1.78 1.83 1.43 1.69 0.81 1.24 1.19 0.95 1.59 1.08
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
572 -143 348 -214 135 191 99 184 -983 230 172
Operating Cash Flow to CapEx
834.59% 666.95% 585.80% 687.11% 758.97% 603.75% 622.94% 581.88% 637.82% 1,403.69% 1,033.86%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.48 0.46 0.43 0.42 0.46 0.48 0.49 0.45 0.53 0.53
Accounts Receivable Turnover
4.45 4.31 4.77 5.50 5.29 5.18 5.57 5.43 4.64 5.57 5.06
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
15.21 14.25 14.31 13.56 11.80 11.16 11.17 12.94 15.83 22.95 20.64
Accounts Payable Turnover
1.40 1.31 1.24 1.28 1.29 1.29 1.34 1.46 1.26 1.39 1.38
Days Sales Outstanding (DSO)
82.01 84.72 76.48 66.37 68.96 70.45 65.53 67.26 78.63 65.56 72.19
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
260.53 278.95 294.47 284.65 283.31 283.34 272.68 249.46 290.08 262.39 265.27
Cash Conversion Cycle (CCC)
-178.52 -194.24 -217.99 -218.28 -214.35 -212.89 -207.15 -182.20 -211.45 -196.83 -193.07
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,440 2,613 2,149 2,238 1,806 1,741 1,742 1,672 1,690 593 686
Invested Capital Turnover
1.08 1.00 0.99 0.95 0.93 0.90 0.85 0.79 0.89 1.45 1.20
Increase / (Decrease) in Invested Capital
-173 464 -90 433 65 -1.09 70 -18 1,098 -93 -75
Enterprise Value (EV)
9,528 11,968 11,313 18,555 16,934 9,067 6,318 5,436 4,263 2,527 2,476
Market Capitalization
10,678 12,696 12,207 19,142 17,692 9,584 6,593 5,513 4,084 3,355 2,976
Book Value per Share
$57.10 $52.50 $47.92 $44.81 $41.09 $36.54 $33.10 $29.17 $25.39 $23.88 $20.19
Tangible Book Value per Share
$24.00 $19.07 $19.15 $14.64 $11.13 $7.57 $2.33 ($2.00) ($6.59) $11.74 $7.39
Total Capital
4,062 4,021 3,720 3,663 3,270 2,722 2,473 2,197 1,977 1,415 1,213
Total Debt
459 666 665 825 681 465 456 448 465 0.00 0.00
Total Long-Term Debt
0.00 457 455 429 421 213 456 448 444 0.00 0.00
Net Debt
-1,163 -742 -907 -600 -783 -517 -275 -77 179 -828 -500
Capital Expenditures (CapEx)
100 84 82 67 63 62 64 68 36 18 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-133 -6.05 -86 -0.51 -306 -253 -249 -223 -130 -149 -146
Debt-free Net Working Capital (DFNWC)
1,489 1,402 1,485 1,424 1,158 186 236 170 58 276 107
Net Working Capital (NWC)
1,030 1,193 1,276 1,028 898 -65 236 170 36 276 107
Net Nonoperating Expense (NNE)
-43 -17 -7.82 19 4.02 3.53 9.30 23 -2.63 -123 -6.35
Net Nonoperating Obligations (NNO)
-1,163 -742 -907 -600 -783 -517 -275 -77 179 -822 -527
Total Depreciation and Amortization (D&A)
197 174 189 210 195 182 165 170 81 61 75
Debt-free, Cash-free Net Working Capital to Revenue
-4.85% -0.25% -3.96% -0.03% -18.58% -16.06% -17.27% -16.71% -12.77% -16.06% -16.76%
Debt-free Net Working Capital to Revenue
54.44% 58.96% 68.09% 74.13% 70.25% 11.84% 16.36% 12.74% 5.67% 29.81% 12.28%
Net Working Capital to Revenue
37.67% 50.16% 58.49% 53.52% 54.48% -4.15% 16.36% 12.74% 3.59% 29.81% 12.28%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$6.97 $5.32 $4.17 $3.15 $3.13 $2.99 $2.60 $2.37 $1.96 $4.35 $1.74
Adjusted Weighted Average Basic Shares Outstanding
63.48M 63.59M 63.79M 63.19M 62.71M 62.12M 61.39M 60.44M 59.67M 59.55M 59.36M
Adjusted Diluted Earnings per Share
$6.76 $5.11 $4.00 $2.98 $2.98 $2.88 $2.52 $2.31 $1.92 $4.22 $1.69
Adjusted Weighted Average Diluted Shares Outstanding
65.51M 66.27M 66.47M 66.90M 65.96M 64.66M 63.31M 62.12M 61.04M 61.28M 60.89M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
63.25M 62.87M 63.63M 63.48M 63.05M 62.40M 61.77M 60.93M 59.99M 59.53M 59.25M
Normalized Net Operating Profit after Tax (NOPAT)
400 322 258 219 200 189 169 105 114 136 102
Normalized NOPAT Margin
14.61% 13.53% 11.83% 11.37% 12.16% 12.04% 11.67% 7.89% 11.25% 14.70% 11.66%
Pre Tax Income Margin
22.11% 19.25% 15.83% 12.52% 14.39% 14.88% 12.93% 9.73% 14.23% 18.49% 12.62%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.69% 0.52% 0.14% 7.91% 0.00% 0.00% 0.00% 6.73% 32.67% 14.77% 37.00%
Augmented Payout Ratio
84.10% 85.79% 54.64% 44.64% 24.59% 25.43% 16.32% 23.77% 69.99% 41.19% 128.46%

Quarterly Metrics And Ratios for NICE

No quarterly metrics and ratios for NICE are available.


Frequently Asked Questions About NICE's Financials

When does NICE's financial year end?

According to the most recent income statement we have on file, NICE's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has NICE's net income changed over the last 10 years?

NICE's net income appears to be on an upward trend, with a most recent value of $442.59 million in 2024, rising from $103.08 million in 2014. The previous period was $338.30 million in 2023. Check out NICE's forecast to explore projected trends and price targets.

What is NICE's operating income?
NICE's total operating income in 2024 was $545.95 million, based on the following breakdown:
  • Total Gross Profit: $1.83 billion
  • Total Operating Expenses: $1.28 billion
How has NICE revenue changed over the last 10 years?

Over the last 10 years, NICE's total revenue changed from $872.00 million in 2014 to $2.74 billion in 2024, a change of 213.7%.

How much debt does NICE have?

NICE's total liabilities were at $1.69 billion at the end of 2024, a 4.0% decrease from 2023, and a 303.5% increase since 2014.

How much cash does NICE have?

In the past 10 years, NICE's cash and equivalents has ranged from $157.03 million in 2016 to $529.60 million in 2022, and is currently $481.71 million as of their latest financial filing in 2024.

How has NICE's book value per share changed over the last 10 years?

Over the last 10 years, NICE's book value per share changed from 20.19 in 2014 to 57.10 in 2024, a change of 182.8%.



This page (NASDAQ:NICE) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners